MERGER ALERT - UROV and GV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies

NEW YORK, NY / ACCESSWIRE / December 07, 2020 / The following statement is being issued by Levi & Korsinsky, LLP:
Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies.

Urovant Sciences Ltd. UROV

Merger Announcement: November 18, 2020
Transaction Details: Sumitovant currently owns 72% of the outstanding shares of Urovant common stock, and under the terms of the merger agreement, will acquire the outstanding shares of Urovant common stock it does not already own at a price of $16.25 per share in cash.

To learn more about the UROV investigation and your rights, go to:
https://www.zlk.com/mna2/urovant-sciences-ltd-information-request-form

The Goldfield Corporation GV
Agreement Announcement: November 24, 2020
Transaction Details: Under the terms of the merger agreement, First Reserve has agreed to acquire all outstanding shares of Goldfield for $7.00 per share in cash, pursuant to a cash tender offer.

To learn more about the GV investigation and your rights, go to:
https://www.zlk.com/mna2/the-goldfield-corporation-information-request-form

Levi & Korsinsky is a nationally recognized firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
jlevi@levikorsinsky.com
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP